Meril
Mumbai, India· Est.
Indian medtech leader delivering affordable orthopedic, cardiovascular and wound‑care devices for emerging markets.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $150M
AI Company Overview
Indian medtech leader delivering affordable orthopedic, cardiovascular and wound‑care devices for emerging markets.
OrthopedicsCardiovascularWound Care
Technology Platform
Proprietary titanium‑alloy/polymer hybrid implants, polymeric drug‑eluting stent coatings, and bio‑active hydrogel wound dressings enabling cost‑effective, high‑performance medical devices.
Opportunities
Expanding domestic demand for affordable implants and export opportunities in emerging markets, coupled with pipeline upgrades in bio‑resorbable and patient‑specific devices.
Risk Factors
Regulatory approval delays, intense competition from multinational medtech firms, and price pressure from government procurement policies.
Competitive Landscape
Competes with Stryker, Zimmer Biomet, and Medtronic; differentiates through cost‑effective domestic manufacturing, strong local distribution, and proprietary hybrid material technologies.